• Skip to main content
  • Skip to footer

Pachyonychia Congenita Project

Fighting for a cure. Connecting & helping patients. Empowering Research.

Donate
VIEW MENUMENU
  • Pachyonychia Congenita
        • What Is Pachyonychia Congenita?
          • Could I Have PC?
          • Getting Diagnosed
          • Genetics
          • Image Library
          • Glossary
          • Brochures
          • Patient Stories
        • Patient Registry (IPCRR)
          • Patient Registry Data
        • Understanding my Genetic Testing Results
          • K6a-pEDD-PC
          • K6b-pEDD-PC
          • K6c-pEDD-PC
          • K16-pEDD-PC
          • K17-pEDD-PC
          • Non-PC Palmoplantar EDDs
        • Managing and Caring For PC
          • Tips and Tools
          • Living With PC
          • PC & Children
          • Working With Medical Professionals
          • Family & Friends: How To Help
          • Video Library
  • For Professionals
        • For Professionals
          • International PC Consortium
          • Pharmaceutical Partners
          • Refer a Patient
          • Patient Registry (IPCRR)
            • Patient Registry Data
            • Non-PC Palmoplantar EDDs
          • Advocacy Partners
        • PC Research
          • Apply for a Grant
          • Awarded Grants
          • Published Research Articles
          • Clinical Trials
        • Patient Voices
          • Quality of Life
          • Patient Stories
          • Patient-Focused Drug Development Meeting
  • Ways To Give
        • Ways You Can Give
          • Donate
          • Donate Just Giving UK
          • Steady Relief Circle
          • Donor-Advised Fund
          • Giving Stock
          • Legacy Society
        • Raise Awareness
          • How You Can Help
          • Fundraising Ideas
          • Share Your Story
          • PC Advocates
          • Volunteer
        • Our Supporters
  • News & Events
        • News
          • Current Newsletter
          • Newsletter Archives
          • Sign up for our Newsletter
        • Events
          • Patient Support Meetings
          • IPCC Meetings
          • Video Library
  • About Us
        • About PC Project
        • Medical and Scientific Advisory Board
        • Financial & Legal Information
        • Contact Us

K6b-pEDD-PC

Patients with mutations in PC-K6b have a milder form of PC, but experience painful plantar keratoderma as the most challenging feature.

ABOUT THE KRT6B GENE

The KRT6B gene provides instructions for making a protein called keratin 6b or K6b. Keratins are a group of tough, fibrous proteins that form the structural framework of certain cells, particularly cells that make up the skin, hair, nails, and similar tissues.  Keratin 6b is produced in the nails, the hair follicles, and the skin on the palms of the hands and soles of the feet. It is also found in the skin’s sebaceous glands, which produce an oily substance called sebum.

Keratin 6b partners with a similar protein, keratin 17, to form molecules called keratin intermediate filaments. These filaments assemble into dense networks that provide strength and resiliency to the skin, nails, and other tissues. Networks of keratin filaments protect these tissues from being damaged by friction and other everyday physical stresses. Keratin 6b is also among several keratins involved in wound healing

The KRT6B mutations responsible for PC-K6b1 change the structure of keratin 6b, preventing it from working effectively with keratin 17 and interfering with the assembly of the keratin intermediate filament network. Without this network, skin cells become fragile and are easily damaged, making the skin less resistant to friction and minor trauma. Even normal activities such as walking can cause skin cells to break down, resulting in the formation of painful blisters and calluses. In the sebaceous glands, abnormal keratin filaments lead to the development of cysts called steatocystomas.  Defective keratin 6b also disrupts the growth and function of cells in the nails and hair follicles, which explains why the signs and symptoms of PC-2 also affect these tissues. (Adapted from http://ghr.nlm.nih.gov/gene/KRT6B.)

1PC classification replacing PC-1 and PC-2 classification. See W. H. McLean et al. The
phenotypic and molecular genetic features of pachyonychia congenita.
J Invest Dermatol. 2011;131(5):1015-7.


To learn how many others have mutations in the same gene and the same mutation, visit the PC data page where there is detailed information on those with PC and the various mutations.


Observations on PC-K6b from the IPCRR

Patients with mutations in PC-K6b have a milder form of PC, but experience painful plantar keratoderma as the most challenging feature.

  • The condition is often not evident at birth, but onset is before age 15 for 90% of patients with PC-K6b.
  • While nearly 100% have some toenail dystrophy, less than 50% have any fingernail dystrophy.
  • Oral leukokeratosis is found in only a small percentage of PC-K6b patients and is usually mild.
  • Cysts and follicular hyperkeratosis FHK are reported in many patients, although the cysts in PC-K6b are not as extensive as those in PC-K17.
  • Plantar keratoderma and pain is experienced by nearly 100% of PC-K6b. Pain levels for PC-K6b patients are often from 3 to 7 on a 0 to 10 scale. This is less than PC-K6a, but significant pain levels.

IPCRR Data for PC-K6b


Plantar keratoderma and pain is experienced by nearly 100% of PC-K6b. Pain levels for PC-K6b patients are often from 3 to 7 on a 0 to 10 scale. This is less than PC-K6a, but significant pain levels.

Plantar Keratoderma97%
Always (never goes away)96%
Sometimes (clears up at times)1%
Seldom (feet usually clear)0%
Plantar Keratoderma – Onset
Birth or less than 1 year4%
1 to 4 years old30%
5 to 14 years old63%
15 years and over2%
Plantar Pain100%
Often require medications for pain19%
Very painful, but do not use medications45%
Somewhat painful32%
Palmar Keratoderma48%
Always (never goes away)23%
Sometimes (clears up at times)9%
Seldom (hands usually clear)17%

While nearly 100% have some toenail dystrophy, less than 50% have any fingernail dystrophy.

Toenail Dystrophy97%
all 10 toenails thickened34%
7-9 toenails thickened17%
4-6 toenails thickened33%
1-3 toenails thickened12%
Toenails – Onset
Birth or less than 1 year13%
1 to 4 years old22%
5 to 14 years old51%
15 years and over13%
Fingernail Dystrophy43%
all 10 toenails thickened6%
7-9 toenails thickened5%
4-6 toenails thickened23%
1-3 toenails thickened9%
Fingernails – Onset
Birth or less than 1 year13%
1 to 4 years old20%
5 to 14 years old33%
15 years and over40%
Note the differences in the fingernails, although both patients have the same mutation.
Oral Leukokeratosis24%
Cysts65%
Follicular Hyperkeratosis39%
Natal or Prenatal Teeth0%

Data from 2021 Sample Size N=93

Footer

PC Project logo in white
PACHYONYCHIA CONGENITA PROJECT

P.O. Box 17850
Holladay, UT 84117

info@pachyonychia.org

801-987-8758

EIN 68-0567493

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Sign up for our Newsletter

Loading

Support PC Project

There are many ways you can help improve the lives of those who suffer from Pachyonychia Congenita.

Learn More
  • Contact Us
  • About Us
  • Donate
  • Patient Registry

Copyright © 2026 PC Project. All rights reserved. Pachyonychia Congenita Project is a 501(c)(3) under federal tax guidelines. Using this site means you accept its terms as outlined in the disclaimer and privacy policy.